Ouro Medicines
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1070 Maryland St Pier 70 Ste 295, San Fr...Website
www.ouromedicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Ouro Medicines
Ouro Medicines founded Ouro Medicines to build the leading immune reset company. Ouro Medicines tackle chronic immune-mediated diseases head-on by combining scientific expertise, a track record of advancing cell-depleting therapies through the clinic, and a robust pipeline.Explore more
Ouro Medicines Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ouro Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Ouro Medicines launches new products
Congratulate Masked Content for being promoted to Masked Content at Ouro Medicines
Earning: See what the market has to say on Ouro Medicines recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Ouro Medicines has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ouro Medicines is spiking on competitors!
Funding: Get notified immidiatlly once Ouro Medicines has new funding data
Click to see if Ouro Medicines had a recent Job posting/layoffs
Ouro Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Ouro Medicines
Find more new buyers
Company Profile Activity
Activity Insights
Ouro Medicines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ouro Medicines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ouro Medicines.
Ouro Medicines financials insights
Gather financial insights about Ouro Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$120M
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Funding
Funding
Ouro Medicines News & Media
Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom
Gilead Sciences (NASDAQ:GILD) executives on Tuesday outlined the company’s rationale for three recently announced transactions—its proposed acquisitions of Tubulis, Ouro Medicines, and Arcellx—framing the deals as additive to an already active late-stage pipeline and consistent with the company’s buGalapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
Galapagos NV (NASDAQ:GLPG) is one of the 7 Fastest Growing European Stocks to Invest In. On March 31, 2026, Galapagos NV (NASDAQ:GLPG) announced a binding agreement with Gilead Sciences (NASDAQ:GILD) related to Gilead’s planned acquisition of Ouro Medicines, a U.S.-based biotech focused on T cell engager therapies for autoimmune diseases. The deal includes access to […]Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
New collaboration structure achieves meaningfully improved financial terms and flexibility for GalapagosGilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. On March 23, The Wall Street Journal reported that Gilead Sciences, Inc. (NASDAQ:GILD) plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion. The company also intends to develop the acquired […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ouro Medicines
Sign Up For FreeTo access detailed company insights
Ouro Medicines founded Ouro Medicines to build the leading immune reset company. Ouro Medicines tackle chronic immune-mediated diseases head-on by combining scientific expertise, a track record of advancing cell-depleting therapies through the clinic, and a robust pipeline.... Read More
